MHRA Acknowledge EU MDR/IVDR Timeline Amendments

In a statement released by the UK’s MHRA, it seems the UK regulator has acknowledged the amendments made to the transitional provisions in the EU MDR and IVDR. Thus, CE-marked products eligible for these new timelines will continue to be allowed to be placed on the UK market.

See the full statement and implication in the following link: